MEDAX
Price
$12.75
Change
-$0.02 (-0.16%)
Updated
Jun 3 closing price
Net Assets
7.65B
MEDIX
Price
$12.71
Change
-$0.02 (-0.16%)
Updated
Jun 3 closing price
Net Assets
7.65B
Interact to see
Advertisement

MEDAX vs MEDIX

Header iconMEDAX vs MEDIX Comparison
Open Charts MEDAX vs MEDIXBanner chart's image
MEDAX vs MEDIX Comparison Chart in %
View a ticker or compare two or three
VS
MEDAX vs. MEDIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDAX is a Hold and MEDIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MEDAX (7.65B) and MEDIX (7.65B) have equal amount of cash in the bank . MEDIX (5.05) and MEDAX (4.80) have matching dividends . MEDAX was incepted earlier than MEDIX: MEDAX (28 years) vs MEDIX (28 years). MEDAX (1.08) is less costly to investors than MEDIX (0.83). MEDAX (69.00) and MEDIX (69.00) have comparable annual turnover. MEDIX has a lower initial minimum investment than MEDAX: MEDIX (0) vs MEDAX (1000). MEDIX (12.40) and MEDAX (12.19) have marching annual gain over last year. MEDIX return over 5 years is better than : 14.96 vs. MEDAX (13.57).
MEDAXMEDIXMEDAX / MEDIX
Total Expense Ratio1.070.82130%
Annual Report Gross Expense Ratio1.080.83130%
Fund Existence28 years28 years-
Gain YTD2.3552.46396%
Front Load4%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.65B7.65B100%
Annual Yield % from dividends4.805.0595%
Returns for 1 year12.1912.4098%
Returns for 3 years33.0634.1197%
Returns for 5 years13.5714.9691%
Returns for 10 years45.6849.3293%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSEDX20.57N/A
N/A
Columbia Intrinsic Value Institutional 2
JRASX92.31N/A
N/A
Janus Henderson Research S
ETCMX15.37N/A
N/A
Eventide Balanced Fund Class C
CBSLX29.70N/A
N/A
ClearBridge Sustainability Leaders R
TWAIX14.47-0.09
-0.62%
Thrivent International Equity S